Response to First-line Recurrence Treatment Influences Survival in Hormone Receptor-positive, HER2-negative Breast Cancer: A Multicenter Study.
Response to First-line Recurrence Treatment Influences Survival in Hormone Receptor-positive, HER2-negative Breast Cancer: A Multicenter Study. — المؤلف: Yamamura, Jun — In vivo (Athens, Greece) 20190404
- المؤلف
- Yamamura, Jun
- النشر
- In vivo (Athens, Greece) 20190404
- الوصف
- 281-287 p.
- الموضوعات
- Adult؛ Aged؛ Biomarkers, Tumor؛ Breast Neoplasms؛ Disease-Free Survival؛ Female؛ Humans؛ Liver Neoplasms